News

Introducing BioPhotas' Latest ELITE Series 2 LED Device

Introducing BioPhotas' Latest ELITE Series 2 LED Device

Revolutionizing Light Therapy with Celluma ELITE S2

BioPhotas Inc., known for their innovative Celluma Light Therapy devices, has just unveiled the Celluma ELITE S2. This latest model is a remarkable advancement in the field of LED light therapy, specifically designed for medical professionals and luxury spa practitioners.

Unmatched Versatility and Features

The Celluma ELITE S2 stands out as the most comprehensive and versatile professional-grade light therapy device available. It uniquely offers five separate FDA-cleared treatment modes that tackle a range of concerns including aging skin, body contouring, acne treatment, hair restoration, and relief from pain. Never before has a device functioned at this level of effectiveness for such diverse applications.

Design That Maximizes Efficiency

What sets the ELITE S2 apart is its modular design. It supports the use of up to three LED panels, enabling three times the treatment coverage in a single session. Additionally, the device comes with large and small interchangeable accessory panels, ensuring that users can focus on specific areas requiring targeted treatment.

Advanced Technology for Optimal Results

The integration of the new Series 2 electronics platform enhances the user experience, featuring a countdown timer, pause treatment function, and controlled therapeutic heat distribution across the LED panel array.

Tailored for Professional Use

Specifically optimized for medical practices and multi-patient care environments, the ELITE S2 is designed for convenience. Its articulating arm and rolling base provide practitioners with the flexibility to cater to their patients' diverse needs effectively. This one-of-a-kind device allows for natural and effective treatments aimed at reversing signs of aging, alleviating acne, and promoting body sculpting while also providing services for hair restoration and pain relief.

Testimonials and User Feedback

"With the Celluma ELITE S2, you can target multiple concerns with precision and ease," remarked Curtis Cluff, CEO of BioPhotas. He emphasized that this device delivers superior results that customers have come to trust from Celluma, noting its versatility and functionality as a major advantage for practitioners seeking effective solutions for their clients.

Pricing and Availability

The ELITE S2 can be acquired as either a three-panel system or as a single panel system, with future expansion options. Pricing starts at $3,995 for a base model consisting of a single panel mounted on an articulating arm, while the more comprehensive three-panel system retails for $5,995.

About BioPhotas, Inc.

BioPhotas prides itself on creating unique devices grounded in NASA-developed technology, backed by rigorous clinical studies. As the manufacturer of the renowned Celluma series, BioPhotas aims to provide safe, effective, and affordable light therapy devices. Their goal is to unlock the clinical potential of low-level light therapy across various healthcare needs, targeting skin, muscle, and joint conditions. For more information about the Celluma products, users can visit the official site.

Frequently Asked Questions

What is the Celluma ELITE S2?

The Celluma ELITE S2 is a cutting-edge LED light therapy device designed for various treatments, including skin rejuvenation and pain relief.

How many treatment modes does the ELITE S2 offer?

The ELITE S2 features five FDA-cleared treatment modes for addressing different health and aesthetic concerns.

Is the ELITE S2 intended for personal or professional use?

This device is specifically designed for professional medical practices and luxury spa environments.

What is the price range for the ELITE S2?

The ELITE S2's pricing ranges from $3,995 for a single panel model to $5,995 for a three-panel configuration.

Where can I find more information about BioPhotas products?

For additional details about BioPhotas and their products, visit their official website or contact their customer service.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Real-World Study Shows Viable Use of Tarlatamab

Updated Category News Views 64

Breaking New Ground in Cancer Care There's a shift happening in the realm of cancer treatment, and OneOncology's latest study on tarlatamab is right at the forefront. Bringing advanced therapies closer to home isn't just a pipe dream anymore. This real-world study, unveiled at the 2026 ESMO Congress, underscores that administering tarlatamab in outpatient settings might...

Continue Reading
Global Wellness Summit 2026: Unpacking Key Agendas

Updated Category News Views 77

Packed Agenda for the Wellness Enthusiast Well, time flies when you're dissecting the wellness industry from the confines of a plush seat at yet another summit. Gunning for attention this time is the Global Wellness Summit 2026, steered into the scenic alleys of Phuket, Thailand, from November 10 to 13. It’s a gathering built to stretch minds, dissect futures, and toast...

Continue Reading
Doximity Lawsuit: What Investors Need to Know Now

Updated Category News Views 56

Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...

Continue Reading
FirstEnergy Funds Boost Housing Stability Across States

Updated Category News Views 68

FirstEnergy's Commitment to Shelter and Safety You know what gives a warm feeling even in the cold, hard world of finance? Watching a company like FirstEnergy put their money where their mouth is with real action in the community. They're dishing out $125,000 in grants across West Virginia and Maryland, targeting groups that help folks dodging homelessness and domestic...

Continue Reading
Posterity Health Boosts Network to Six New Markets

Updated Category News Views 90

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 44

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Strategic Resources Faces Board Shakeup, AGM Announced

Updated Category News Views 97

A Shift in Strategic Resources' Boardroom Dynamics On days like these, companies aren't just ticking boxes. They're repositioning themselves for a future painted with a whole bunch of ‘what ifs’, and Strategic Resources Inc. is no exception. This isn’t just your run-of-the-mill board shuffle—Michael Moore’s resignation marks a pivot moment. Now, you might ask...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 34

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 103

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 126

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Royal Caribbean's Artist Discovery Program Welcomes New Talents

Updated Category News Views 350

Royal Caribbean Unveils New Artists for Their Discovery Program The Artist Discovery Program shines a spotlight on the creative expressions of Caribbean artists aboard the cruise line's latest ship, Star of the Seas. Celebrating Local Culture Through Art At Royal Caribbean, celebrating local cultures is paramount. As the cruise line embarks on a journey to showcase the...

Continue Reading
Neumora Therapeutics Faces Class Action Over Allegations

Updated Category News Views 273

Neumora Therapeutics Faces Class Action Lawsuit Recently, a class action lawsuit has been initiated against Neumora Therapeutics, Inc. (NASDAQ: NMRA), a clinical-stage biopharmaceutical company. This legal action has been brought forth by investors who claim they were misled by the company’s initial public offering (IPO) documents. The allegations denote a significant...

Continue Reading
LaSalle Investment Management Expands with New Acquisition

Updated Category News Views 337

LaSalle Investment Management Acquires Tempe Commerce Park LaSalle Investment Management has recently announced a significant acquisition, continuing to bolster its portfolio in the industrial real estate sector. The company has successfully acquired Tempe Commerce Park, an extensive industrial complex located in a metropolitan area renowned for its growth and...

Continue Reading
Practical Tips for Water Conservation and Lower Bills

Updated Category News Views 210

Effective Strategies for Water Conservation Homeowners across the country are increasingly recognizing the importance of water conservation. By taking small, proactive measures, families can significantly lower their water usage and reduce utility costs. Plumbing professionals emphasize the value of implementing water-efficient practices that not only benefit the...

Continue Reading
Soleno Therapeutics Awards Inducement Grants to New Employees

Updated Category News Views 75

Soleno Therapeutics Announces Inducement Grants Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on creating innovative treatments for rare diseases, has revealed that it has granted inducement awards to six new employees, in accordance with Nasdaq Stock Market regulations. Details of the Inducement Awards The...

Continue Reading